API: Exclusive supply still a ‘very big issue’

The CEO of one of Australia’s leading pharmaceutical distributors says he wishes a solution had been organised “yesterday” Exclusive supply of medicines is still a “very big issue”, says Richard Vincent, CEO and Managing Director of Australian Pharmaceutical Industries (API) and Deputy Chairman of the National Pharmaceutical Services Association (NPSA), which represents Australian pharmaceutical wholesalers.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous This sporting life
Next How the profession celebrated